ZIAGEN
Google image searchProduct monograph
Active ingredient
abacavir (abacavir sulfate), 20 MG/ML
DIN: 02240358
Dosage form(s): SOLUTION
Route(s) of administration: ORAL
Schedule: Prescription
Company: VIIV HEALTHCARE ULC
Date: 25-NOV-2010
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AF — Nucleoside and nucleotide reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AF06 — ABACAVIR (ATC/DDD)
Reference brand drug: Ziagen
